Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in theme_biblio_custom() (line 367 of /home/phcogcommn/



Pharmacognosy Communications,2021,11,2,66.
Published:April 2021


Ian Edwin Cock1,2,*

1Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.

2School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.


Dear readers and authors,

I am pleased to bring you Volume 11, Issue 2 of Pharmacognosy Communications. In this issue, we present new research reports examining the Pharmacognosy of several important medicinal plants including the antibacterial activity of the Australian plant species Kunzea ambigua (Sm.) Druce and Kunzea flavescens C.T.White and W.D.Francis essential oils, as well as Mirbelia oxylobioides F.Muell. leaf extracts against pathogenic bacteria. We also present a study examining the antimicrobial potential of Eucalyptus baileyana F. Muell. and Eucalyptus major (Maiden) Blakely against the fish spoilage-causing bacterium Shewanella putrefaciens. We also include a number of other studies on medicinal plants and their constituents, including examinations of the hypoglycaemic effects of Fagonia indica leaf extracts, the antiviral properties of some TCM and Iranian medicinal plants against viral hepatitis, the pharmaceutical properties of Trachyspermum ammi L., an examination of the anti-proliferative activity of Hibiscus sabdariffa L. calyx flavonoid extracts on cervical cancer cells using flow cytometry, the antibacterial activities and phytochemical screening of crude extracts from Kenyan Macaranga species towards effux pump expression, as well as a review on toxicological compounds from plants. We also present a study describing the chromatography assisted validation of alternate plant materials in a polyherbal formulation.

Our regular features are also continued in this issue. Two more high quality medicinal plant images are also included in this issue and a listing of upcoming conferences and meetings is also included. I encourage any conference organisers who would like to publicise their event to contact me with details so they can be included in future upcoming events sections of this journal. I look forward to bringing you the next issue of Pharmacognosy Communications in 3 months’ time. Keep submitting your quality research manuscripts and reviews and also consider becoming involved/submitting to the other sections (Janus Corner, Medicinal Plant Images etc.) of the journal. On behalf of the editorial board, we look forward to bringing you the next issue of Pharmacognosy Communications in 3 months’ time. Read more....

Cite This Article

Vancouver Style :: Cock IEdwin. Editorial. Pharmacognosy Communications. 2021;11(2):66.  (316.03 KB)
MLA Style: Cock IEdwin. Editorial. Pharmacognosy Communications. 2021;11(2):66.  (316.03 KB)
CSE Style: Cock IEdwin. Editorial. Pharmacognosy Communications. 2021;11(2):66.  (316.03 KB)
APA Style: Cock IEdwin. Editorial. Pharmacognosy Communications. 2021;11(2):66.  (316.03 KB)

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.